Last updated: June 14th, 2007

Recent support has come from NIST/SBIR funded grant programs for new technological development. A Phase II SBIR grant was also awarded. (Click here to see our awards from the NIH and NIST.)

We have developed different transplantation systems in mice: pancreatic islet, liver, and heart transplantations. We have established experimentally that Isogenis' approach permanently protected tissues from rejection.

Isogenis has recently set collaborations with the University of Minnesota and ISNETT - University of Pittsburgh to test its approach in large animals.